Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 2
1958 1
1959 1
1962 3
1963 1
1969 1
1970 1
1971 1
1973 2
1974 3
1975 1
1976 1
1977 2
1978 2
1979 2
1980 4
1981 2
1982 5
1983 2
1984 3
1985 1
1986 3
1987 13
1988 5
1989 9
1990 13
1991 8
1992 10
1993 11
1994 21
1995 17
1996 19
1997 37
1998 33
1999 40
2000 63
2001 79
2002 83
2003 92
2004 120
2005 158
2006 178
2007 243
2008 251
2009 270
2010 339
2011 317
2012 364
2013 379
2014 340
2015 393
2016 409
2017 447
2018 430
2019 431
2020 456
2021 531
2022 483
2023 459
2024 435
2025 388
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,448 results

Results by year

Filters applied: . Clear all
Page 1
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial.
Marth C, Moore RG, Bidziński M, Pignata S, Ayhan A, Rubio MJ, Beiner M, Hall M, Vulsteke C, Braicu EI, Sonoda K, Wu X, Frentzas S, Mattar A, Lheureux S, Chen X, Hasegawa K, Magallanes-Maciel M, Choi CH, Shalkova M, Kaen D, Wang PH, Berger R, Okpara CE, McKenzie J, Yao L, Orlowski R, Khemka V, Gilbert L, Makker V; ENGOT-en9/LEAP-001 Investigators. Marth C, et al. Among authors: choi ch. J Clin Oncol. 2025 Mar 20;43(9):1083-1100. doi: 10.1200/JCO-24-01326. Epub 2024 Nov 26. J Clin Oncol. 2025. PMID: 39591551 Free PMC article. Clinical Trial.
Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial.
Colombo N, Biagioli E, Harano K, Galli F, Hudson E, Antill Y, Choi CH, Rabaglio M, Marmé F, Marth C, Parma G, Fariñas-Madrid L, Nishio S, Allan K, Lee YC, Piovano E, Pardo B, Nakagawa S, McQueen J, Zamagni C, Manso L, Takehara K, Tasca G, Ferrero A, Tognon G, Lissoni AA, Petrella M, Laudani ME, Rulli E, Uggeri S, Barretina Ginesta MP; AtTEnd study group. Colombo N, et al. Among authors: choi ch. Lancet Oncol. 2024 Sep;25(9):1135-1146. doi: 10.1016/S1470-2045(24)00334-6. Epub 2024 Aug 2. Lancet Oncol. 2024. PMID: 39102832 Clinical Trial.
Proteogenomic analysis reveals non-small cell lung cancer subtypes predicting chromosome instability, and tumor microenvironment.
Song KJ, Choi S, Kim K, Hwang HS, Chang E, Park JS, Shim SB, Choi S, Heo YJ, An WJ, Yang DY, Cho KC, Ji W, Choi CM, Lee JC, Kim HR, Yoo J, Ahn HS, Lee GH, Hwa C, Kim S, Kim K, Kim MS, Paek E, Na S, Jang SJ, An JY, Kim KP. Song KJ, et al. Among authors: choi cm. Nat Commun. 2024 Nov 23;15(1):10164. doi: 10.1038/s41467-024-54434-4. Nat Commun. 2024. PMID: 39580524 Free PMC article.
Authors' Reply.
Lim S, Chung YE, Seo JH, Choi CH, Lee Y, Kato K, Lee YL, Chen YL. Lim S, et al. Among authors: choi ch. J Minim Invasive Gynecol. 2025 Aug 11:S1553-4650(25)00295-X. doi: 10.1016/j.jmig.2025.08.007. Online ahead of print. J Minim Invasive Gynecol. 2025. PMID: 40803505 No abstract available.
Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline).
Kim IH, Kang SJ, Choi W, Seo AN, Eom BW, Kang B, Kim BJ, Min BH, Tae CH, Choi CI, Lee CK, An HJ, Byun HK, Im HS, Kim HD, Cho JH, Pak K, Kim JJ, Bae JS, Yu JI, Lee JW, Choi J, Kim JH, Choi M, Jung MR, Seo N, Eom SS, Ahn S, Kim SJ, Lee SH, Lim SH, Kim TH, Han HS; Development Working Group for the Korean Practice Guideline for Gastric Cancer 2024 Task Force Team. Kim IH, et al. Among authors: choi ci. J Gastric Cancer. 2025 Jan;25(1):5-114. doi: 10.5230/jgc.2025.25.e11. J Gastric Cancer. 2025. PMID: 39822170 Free PMC article. Review.
Heteroatom-Substituted Reflashed Graphene.
Scotland P, Eddy L, Chen J, Chen W, Beckham JL, Wyss KM, Choi CH, Advincula PA, Lathem A, Onah OE, Han Y, Tour JM. Scotland P, et al. Among authors: choi ch. ACS Nano. 2025 Apr 1;19(12):11987-11998. doi: 10.1021/acsnano.4c16959. Epub 2025 Mar 21. ACS Nano. 2025. PMID: 40117566
Genetic evidence against involvement of TRPC proteins in SOCE, ROCE, and CRAC channel function.
Susperreguy S, Yamashita M, Choi CI, Liao Y, Burch LH, Blankenship TL, Hayes E, Sliwa T, Zhang Y, Grenet D, Walker M, Plummer NW, Abramowitz J, Kinet JP, Formoso K, Johnson BE, Fleig A, Hazlehurst L, Penner R, Freichel M, Flockerzi V, Prakriya M, Birnbaumer L. Susperreguy S, et al. Among authors: choi ci. Proc Natl Acad Sci U S A. 2024 Dec 3;121(49):e2411389121. doi: 10.1073/pnas.2411389121. Epub 2024 Nov 27. Proc Natl Acad Sci U S A. 2024. PMID: 39602257 Free PMC article.
GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator's choice of treatment in patients with recurrent low grade serous ovarian cancer.
Grisham R, Monk BJ, Van Nieuwenhuysen E, Moore KN, Fabbro M, O'Malley DM, Oaknin A, Thaker P, Oza AM, Colombo N, Gershenson D, Aghajanian CA, Choi CH, Lee YC, Mirza MR, Coleman RL, Cobb L, Harter P, Lustgarten S, Youssoufian H, Banerjee S. Grisham R, et al. Among authors: choi ch. Int J Gynecol Cancer. 2025 Nov;35(11):101832. doi: 10.1136/ijgc-2024-005919. Epub 2025 Apr 19. Int J Gynecol Cancer. 2025. PMID: 39375168 Free article.
7,448 results